937663-34-8

Basic information

• Product Name: 4-(4-methoxyphenylsulfonyl)piperazine-1-carbothioamide
• Synonyms: 4-(4-methoxyphenylsulfonyl)piperazine-1-carbothioamide
• CAS NO: 937663-34-8
• Molecular Weight: 315.417
• Mol File: 937663-34-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(4-methoxyphenylsulfonyl)piperazine-1-carbothioamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-methoxyphenylsulfonyl)piperazine-1-carbothioamide(937663-34-8)
• EPA Substance Registry System: 4-(4-methoxyphenylsulfonyl)piperazine-1-carbothioamide(937663-34-8)

Safety Data

• Hazardous Substances Data: 937663-34-8(Hazardous Substances Data)

Upstream product

• 6160-65-2 1,1'-Thiocarbonyldiimidazole 
• 121751-67-5 1‐(4‐methoxyphenylsulfonyl)piperazine 

Downstream Products

• 1114770-32-9 2-(4-(4-methoxyphenylsulfonyl)piperazin-1-yl)-4-(thiophen-2-ylmethyl)-thiazole 
• 1239437-25-2 2-(4-(4-methoxyphenylsulfonyl)piperazin-1-yl)-4-(3-methylbenzyl)-thiazole 
• 1114770-34-1 3-((2-(4-(4-methoxyphenylsulfonyl)piperazin-1-yl)thiazol-4-yl)methyl)-benzonitrile 
• 1114770-35-2 4-(3-fluorobenzyl)-2-(4-(4-methoxyphenylsulfonyl)piperazin-1-yl)thiazole 
• 1239437-26-3 4-(benzo[d][1,3]dioxol-5-ylmethyl)-2-(4-(4-methoxyphenylsulfonyl)-piperazin-1-yl)thiazole 
• 1114770-37-4 4-(2-methoxybenzyl)-2-(4-(4-methoxyphenylsulfonyl)piperazin-1-yl)thiazole 
• 1114770-36-3 4-(4-methoxybenzyl)-2-(4-(4-methoxyphenylsulfonyl)piperazin-1-yl)-thiazole 

Relevant articles and documents

N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES

This invention provides thiazolylpiperazine derivatives, and N-sulfonyl heterocyclic derivatives including phenyl- and benzyl-thiazolylpiperidine derivatives, and pharmaceutically acceptable salts thereof, which are useful active ingredients for administration in a method for the treatment of an α-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides methods for making such derivatives, and pharmaceutical compositions including such derivatives together with pharmaceutically acceptable excipients.